Alejandro Balsa

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.6K citations · Full text

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Josef S Smolen, Robert Landewé, Sytske Anne Bergstra et al. · Annals of the Rheumatic Diseases · 2022 · 1.6K citations · Full text

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Maxime Dougados, Martin Soubrier, Anna Antunez et al. · Annals of the Rheumatic Diseases · 2013 · 841 citations · Full text

Association of a functional single‐nucleotide polymorphism of <i>PTPN22</i>, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus

Gisela Orozco, Elena Sánchez, Miguel Á. González‐Gay et al. · Arthritis & Rheumatism · 2005 · 314 citations

Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis

Dora Pascual‐Salcedo, C. Plasencia, S. Ramiro et al. · Lara D. Veeken · 2011 · 253 citations · Full text